What Basic Physiological Change Underlies Most Cardiovascular Disease?
J Appl Physiol (1985). 2013 Nov i; 115(9): 1219–1226.
Physiology in Medicine: Peripheral arterial disease
Received 2013 Aug 1; Accepted 2013 Aug 19.
Abstract
Peripheral arterial illness (PAD) is an atherosclerotic condition that can provoke symptoms of leg pain ("intermittent claudication") during exercise. Because PAD is oft observed with comorbid weather condition such hypertension, dyslipidemia, diabetes, cigarette smoking, and/or physical inactivity, the pathophysiology of PAD is certainly complex and involves multiple organ systems. Patients with PAD are at high risk for myocardial infarction, stroke, and all-cause mortality. For this reason, a better physiological understanding of the pathogenesis and treatment options for PAD patients is necessary and forms the basis of this Physiology in Medicine review.
Keywords: ischemia, claret pressure, blood flow, claudication, exercise
peripheral arterial disease (PAD) is typically acquired by progressive narrowing of the arteries in the lower extremities. This status affects 5–12 million Americans (43, 75), and the authentication symptom is exertional hurting in the buttocks, thigh or calf that promptly resolves with residual, termed "intermittent claudication." Still, only x–fifteen% of patients accept classic claudication symptoms. In office because of the varied and often nonspecific presentation of symptoms, PAD remains poorly understood by the public, it is under-diagnosed in the primary care setting, and patients rarely receive optimal treatment (43, 44). Considering PAD is an atherosclerotic disease, it is not surprising that patients with PAD are at loftier chance for myocardial infarction, stroke, and all-cause mortality (twenty). Indeed, patients with a history of PAD accept the same relative risk of cardiovascular decease as patients with coronary or cerebrovascular disease (19, 33). To further emphasize this fact, patients with PAD are three times more likely to dice over the next ten years compared with healthy individuals (20). From a physiological standpoint, the diagnosis and treatment of PAD involves fundamentals of fluid dynamics, metabolism, autonomic control of claret pressure, and the integration of multiple trunk systems. In this report, nosotros describe 1) the pathogenesis of atherosclerosis (Fig. one); ii) the clinical presentation and diagnosis of PAD; 3) the physiological consequences of chronic limb ischemia (Table 1); and four) the physiological ground of current and hereafter therapies in PAD (Table 2 and Fig. 2).
Pathogenesis of peripheral arterial disease (PAD). Figure outlines the predisposing factors and molecular pathways that convert a health avenue (left) into an artery with PAD (right).
Table 1.
Physiological consequences of chronic limb ischemia
| Physiological Consequences | |
|---|---|
| Already Adamant | |
| Number and size of type 1 muscle fibers | ↓ |
| Capillary density in leg muscle | ↓ |
| Muscle and blood levels of acylcarnitines | ↑ |
| Muscle lactate accumulation during do | ↑ |
| Maximal oxygen uptake | ↓ |
| Endothelial role of limb blood vessels | ↓ |
| Systemic markers of inflammation | ↑ |
| Systemic markers of coagulation | ↑ |
| Rise in arterial claret pressure level during exercise | ↑ |
| Possible Associations Not Yet Determined | |
| Compensatory vasodilation of limb blood vessels | |
| Neurovascular transduction of sympathetic outflow | |
| Baroreflex sensitivity | |
| Chemoreflex sensitivity | |
| Coronary dilator capacity | |
| Renin-angiotensin-aldosterone involvement |
Table 2.
Benefits of exercise training in humans with PAD
| Benefits | References |
|---|---|
| Functional Benefits | |
| Improved maximal walking distance | 31, 38–40, 61, 70 |
| Improved pain gratuitous walking distance | 31, 38–40 |
| Increased quality of life | 31, 71 |
| Increased costless-living physical activeness | 61, lxx, 71 |
| Physiological Benefits | |
| Decreased systemic inflammation | 80, 84 |
| Increased endothelial office | 8, 57 |
| Increased skeletal muscle oxidative capacity | 28, 38, 39 |
| Increased maximal oxygen uptake | 28, 31, 38–40, 70 |
Physiological footing of novel mechanical therapies in PAD. Intermittent pneumatic calf pinch (IPCC) has been widely studied in patients with PAD ranging from mild to severe leg symptoms (left). Remote ischemic preconditioning (RIPC) and enhanced external counterpulsation (EECP) have not yet been prospectively tested in PAD but there is stiff physiological rationale for why these therapies may improve leg symptoms and reduce systemic cardiovascular illness take chances. Taken together, mechanical therapies are likely to be an constructive alternative or adjunct therapy to dynamic exercise training in PAD.
PATHOGENESIS OF ATHEROSCLEROSIS
As recently stated (30), "Atherosclerosis is a chronic immunoinflammatory, fibroproliferative disease of large and medium-sized arteries fueled by lipid." This all-encompassing definition involves physiological processes at the cellular and molecular levels. The basic steps in the germination of an intraluminal thrombus (due east.thou., in the leg of a PAD patient) are as follows. Get-go, LDL cholesterol from the blood passes through the dysfunctional endothelial cells and enters the intima media where it is oxidized. Second, monocytes sense the local inflammation and migrate to the arterial wall. Third, monocytes engulf the oxidized LDL and get cream cells, which appear histologically as a fatty streak. When the foam cells die, they release their lipid content, creating a lipid core. 4th, polish muscle cells proliferate and form a fibrous cap over the lipid core. Fifth, equally more LDL accumulates, the external elastic membrane will expand (i.east., outward remodeling) in an effort to maintain blood period. Eventually, the vessel will not be able to recoup and the plaque will protrude into the lumen, thereby raising both resistance and stiffness. Over time, subclinical plaque rupture followed by normal healing is a major physiological mechanism by which thrombi increment in size and reduce perfusion to distal targets.
It is important to emphasize that environmental irritants (eastward.chiliad., cigarette smoking) and cardiometabolic hazard factors (i.east., hypertension, hyperlipidemia, diabetes, and physical inactivity) as well as genetic factors contribute to the initial stages of this process (Fig. i). It should besides be noted that there is considerable overlap and redundancy between the stages. For instance, oxidized LDL reduces the germination of nitric oxide and potentiates the formation of endothelin-1 (78). The circulating hormone angiotensin II promotes atherosclerosis by forming reactive oxygen species (ROS) in macrophages, endothelial cells, and vascular smooth muscle cells. These ROS contribute to further oxidation of LDL cholesterol. Taken together, a variety of cytokines, growth factors, hormones, and adhesion molecules participate in the formation of an intraluminal thrombus. Why this procedure manifests itself in the lower extremity of PAD patients is not entirely clear.
CLINICAL PRESENTATION AND DIAGNOSIS OF PAD
A patient with suspected PAD will undergo measurement of the ankle-brachial alphabetize (ABI) at residual. Because perfusion to the lower extremity is reduced in PAD, the ankle blood pressure level will exist lower than the brachial blood force per unit area; lower ABIs (i.eastward., more severe disease) correlate with mortality (20, 63). It is interesting that in the electric current loftier-tech state of medicine, the diagnosis of PAD is largely based on straightforward integrative physiology techniques relating claret force per unit area and claret flow. Prior big-scale studies have advocated that anyone >50 yr who is a smoker or diabetic and all people >70 year receive ABI measurements (1). Postexercise ABI measurements may provide additional sensitivity (1). The qualitative Fontaine stages (I = asymptomatic, II = claudication, III = ischemic balance pain, IV = tissue loss or gangrene) and Rutherford stages (0 = asymptomatic, 1 = balmy claudication, ii = moderate claudication, three = severe claudication, 4 = ischemic rest pain, v = minor tissue loss, 6 = ulceration or gangrene) are used to grade severity of limb ischemia (48, 64). In addition to symptoms of leg pain, PAD patients with advanced disease may too present with pare atrophy, loss of pilus, coldness, and nonpalpable pulses.
PHYSIOLOGICAL CONSEQUENCES OF CHRONIC LIMB ISCHEMIA
Metabolism in ischemic musculus.
PAD is not solely a disease of circulatory insufficiency. Because of the chronic depression-flow state, PAD patients take metabolic dysfunction within skeletal muscle that makes them less able to apply the oxygen that is delivered. A series of studies were conducted demonstrating that PAD patients accumulate acylcarnitines in both the plasma and muscle during short duration practice (5, 37). This indicates that substrates are not effectively oxidized in PAD and suggests that distal flow limitation alters oxygen utilization. In fact, resting levels of acylcarnitine inversely correlate with claudication-limited top aerobic chapters (V̇o 2 max) (41). Relative to control subjects, patients with PAD as well have fewer blazon I fibers, accumulate lactate at lower exercise intensities, take reductions in some electron send chain enzymes, and take dumb oxygen uptake kinetics (5, vi). Equally noted in Table 2, practice training can restore many of these impairments. On a physiological level, information technology is interesting that PAD patients accept increased mitochondrial content in skeletal muscle every bit well as increased mitochondrial enzyme activity (39). Previous investigators have hypothesized that these adaptations might improve oxygen utilization under low-flow atmospheric condition (five).
The physiological differences between acute and chronic reductions in peripheral blood flow (i.e., ischemia) should exist noted. Compared with acute ischemia via cuff occlusion or intra-arterial balloon inflation, PAD is characterized by chronic limb ischemia due to atherosclerosis too every bit historic period-related impairments in vascular compliance. Thus an impaired ABI is due to the net furnishings of structural/mechanical changes within the arterial wall, functional impairments in compensatory vasodilation, and physical blockage of menstruum by atherosclerotic plaque (typically observed in large conduit arteries). Fundamentally, ischemia (and also hypoxemia) impairs O2 delivery to skeletal muscle, and the local vasculature tin can dilate in an endeavour to increment claret flow and O2 availability. This classic "supply and demand" rest is well established in both health and disease and is a central concept of physiology (27).
Using an intra-arterial balloon catheter to impede blood catamenia to the working forearm musculus in healthy subjects, Casey and Joyner (12, fourteen) recently demonstrated that astute hypoperfusion of the forearm leads to a compensatory vasodilation (i.e., to remainder the acute impairment in O2 commitment) at rest and during low-intensity practice. Indeed, the magnitude of flow restoration correlated to the reduction in downstream vascular resistance (13) and nitric oxide and adenosine both were involved (12). The arterial balloon catheter model of Casey and Joyner is an advanced experimental technique that allows researchers to determine cause-and-effect mechanisms of astute limb ischemia across the use of external cuff compression. However, this technique is invasive and does non study atherosclerotic ischemia per se, but rather ischemia due to mechanical reductions in limb blood flow. Whether PAD patients are in a chronic land of hypoperfusion that leads to local reduction in vascular resistance (i.east., distal to a stenosis) is plausible but needs to exist experimentally tested.
Endothelial role and claret markers of vascular wellness.
The endothelium is a monolayer of cells within blood vessels that participates in hemostasis, inflammation, and angiogenesis. Importantly, endothelial cells produce a myriad of factors that can increase or decrease vasomotor tone (85). Endothelial part tin can be experimentally tested in the limb and coronary arteries using a variety of invasive and noninvasive approaches (79). Epidemiological studies propose that PAD patients have severely compromised endothelial function in the limbs, and this is likely due to the combined furnishings of oxidative stress, inflammation, elevated serum lipids, and impaired ability of endothelial cells to produce nitric oxide (9, x). Indeed, levels of fibrinogen and C-reactive protein are elevated in PAD (ix, 50, 67). Additionally, Pellegrino et al. (66) demonstrated that impairments in peripheral vascular endothelial part in PAD patients (brachial artery flow-mediated dilation) correlate to coronary menstruum reserve (i.e., a measure of coronary vasodilator capacity). This linkage is important to sympathise because patients with PAD have a high incidence of coronary affliction (32).
HDL cholesterol is typically lower and LDL cholesterol and triglycerides are college in PAD patients relative to salubrious controls. Plasma-antiplasmin complex, a hemostatic activation marker, is elevated in PAD and may be able to identify patients at a higher gamble for hereafter myocardial infarction (21, 67). Cigarette smoking conspicuously enhances the progression of atherosclerosis (52). The renin-angiotensin-aldosterone system in PAD patients has non been comprehensively studied, simply it is known that ACE inhibitors tedious the progression of atherosclerosis and may favorably do good functional capacity (17). Taken together, several pathophysiological processes are evident in PAD that reflect systemic atherosclerosis in addition to local reductions in blood flow.
Autonomic control of claret pressure level and blood flow.
The sympathetic nervous organization serves as the principal integrated controller of myocardial function, regional distribution of blood flow, and blood pressure. Many cardiovascular affliction states are associated with heightened sympathetic tone (eleven, 29). Specifically, preclinical and clinical studies in hypertension, heart failure, obstructive slumber apnea, and renal disease provided evidence that basal sympathetic activity every bit determined by heart rate variability, circulating levels of the sympathetic neurotransmitter norepinephrine, and straight measured sympathetic vasoconstrictor nerve activity (via microneurography) is increased and predicts cardiovascular risk (xi, 29). A straight consequence of enhanced sympathetic activity is increased vasoconstrictor tone in the target organ(southward), which decreases regional blood flow unless it is counterbalanced by a commensurate increment in claret pressure (perfusion pressure level). Furthermore, increased sympathetic tone may contribute to endothelial dysfunction (42), a hallmark in the development of atherosclerotic disease. Nonetheless, it is of import to appreciate that under physiologic conditions, sympathetic activity to different target tissues (skeletal muscle, kidneys, coronary arteries, etc.) may be highly variable, and some of these target territories are very difficult to study in humans (29).
An understanding of the specific role of sympathetic neural command and dysregulation in PAD is very limited. Most patients with PAD suffer from comorbid conditions such every bit hypertension, diabetes mellitus, and renal disease, and many are cigarette smokers, atmospheric condition that past themselves are known to be associated with sympathetic activation and vascular dysfunction (15, 29, 34, 62). Therefore, the pattern of sympathetic neural regulation in PAD is likely the result of the integrated effects of reflex interactions, altered central integration, and vascular dysfunction and remodeling. To what extent sympathetic overactivity and dysregulation are cause or event of the underlying disease process, by what mechanism the sympathetic nervous system is activated and modulated, whether it straight contributes to illness progression, and how it exerts its potential adverse effects on the cardiovascular system in humans are topics of continued argue. One postulated mechanism of sympathetic activation involves enhanced central expression of angiotensin II and renin-angiotensin-aldosterone system (RAAS) activity, promoting generation of reactive oxygen species and inflammation that effect in impaired baroreflex restraint and heightened peripheral chemoreflex sensitivity (26, 65, 68, 86, 88). The contribution of renal sympathetic nerves to this process in humans is an area of active investigation (74). In another model of sympathetic activation produced past intermittent hypoxia (68), downstream furnishings of the generation of the transcription factor hypoxia-inducible-factor (HIF)-1α, including oxidative stress, appear to exist crucial (76). This model is highly relevant to hypertension in full general and to the furnishings of smoking.
PAD patients accept an augmented blood pressure response to dynamic exercise (two, 3, 55). Our laboratory recently demonstrated that this was due in office to an augmented muscle mechanoreflex (relative to good for you controls) and that oxidative stress may exist involved (60). Recent studies provide evidence that the muscle metaboreflex is also augmented in a rodent model of PAD (82, 83, 87). As recently reviewed by Li and Xing (54), alterations in metabolically sensitive muscle afferent receptors (transient receptor potential vanilloid blazon i, purinergic P2X, acid sensing ion channel) announced to underlie the augmented blood pressure response to muscle contraction in this model. The augmented pressor response to exercise in PAD may be a normal compensatory response to heighten skeletal musculus blood menstruation, but high afterload may damage the encephalon and heart over time. Prospective studies relating astute exercise adaptations to long-term medical outcomes are needed. Because dynamic exercise is the primary stimulus that provokes symptoms in PAD and because patients with more severe disease take larger pressor responses to practise (lx), we believe understanding this process is of paramount physiological and medical importance. Future piece of work in PAD patients who besides accept diabetes may clarify how an augmented pressor response to practice influences limb role.
In addition to the sympathetic nervous arrangement, vagal activity, typically inversely related to sympathetic activity, may too play a role. Vagal action tin exert important anti-inflammatory effects, thus potentially inhibiting vascular inflammation that underlies systemic atherosclerosis (81). Conversely, in a hypertensive rodent model, sympathetic activation has been shown to promote cardiac fibrosis (cardiac remodeling) via furnishings on monocytes (53). Whether reduced sympathetic action or enhanced vagal activity would interpret into anti-inflammatory effects on blood vessels in humans with PAD is unknown.
PHYSIOLOGICAL BASIS OF Current AND Futurity THERAPIES IN PAD
Handling for patients with PAD is aimed at improving maximal walking distance and functional chapters too equally reducing cardiovascular affliction risk. Previous publications accept outlined the medical, surgical, and lifestyle management of this progressive disease (36, 64). The following section volition focus on the physiological mechanisms by which the following treatments are effective: 1) medical therapy; two) surgical intervention; 3) exercise training; and 4) mechanical therapy.
Medical therapy.
Drug treatment with statins and antiplatelet agents is necessary for the secondary prevention of coronary and cerebrovascular disease in PAD patients. Considering of the prevalence of comorbid weather condition, smoking cessation, blood glucose management, and treatment of hypertension and obesity is also required (36, 64). Medical management is aimed at symptom relief and slowing progression of atherosclerotic disease. Although at that place take been a number of drugs evaluated for employ in patients with claudication, efficacy is only noted for cilostazol and antiplatelet agents (16, 72). Cilostazol is a phosphodiesterase inhibitor that suppresses platelet assemblage; information technology is too a straight vasodilator. Patients can note improvement in maximal and pain-complimentary walking distance in as short as four wk. Other phosphodiesterase inhibitors have been noted to increase mortality in patients with avant-garde center failure, thus cilostazol is contraindicated in patients with any level of heart failure (36). Taken together, these above medications are physiologically effective if they ameliorate blood period to the limb, prevent lipid accumulation and oxidation, and prevent coagulation (i.due east., preventing further progression of atherosclerosis). However, epidemiological evidence suggests that many patients do not receive symptom relief with medical therapy alone; the physiological rationale is likely because drugs are not able to enhance limb blood flow to the levels observed with other therapies (listed below).
Surgical intervention.
Restoration of limb blood flow can be achieved through angioplasty (with or without the addition of atherectomy), stenting, and lower extremity bypass. Percutaneous management has the advantage of being less invasive, avoiding infection and incision and generally being performed as an outpatient. When conservative measures neglect and claudication becomes lifestyle limiting, angiography with intention to treat becomes a logical next pace. Femoral arterial access is often utilized with 5–7 Fr. sheaths typical for intervention. If percutaneous treatment is deemed not possible past the physician, proximal and distal targets will exist identified on angiography for lower extremity bypass planning. Autogenous conduits using great saphenous vein is preferred over prosthetic graft that carries a higher risk of infection, thrombosis, and decreased limb salvage compared with vein. Hybrid procedures exist that can combine these 2 modalities—endovascular and open vascular surgery—under one anesthetic. Hybrid operating rooms are becoming increasingly common and offer many advantages for the patient, including the ability often to make the unabridged procedure less invasive, every bit well as combining two procedures into one. On a physiological level, it is non surprising that surgically removing an obstruction to flow improves symptoms in PAD. How these standard of care procedures influence other torso systems (e.grand., musculus metabolism, autonomic nervous organization, inflammatory processes) is an expanse for hereafter investigation.
Practice training.
The benefits of practice preparation in PAD are well established and are outlined in Table 2. Equally noted by Hamburg and Balady (35) in a recent review, the electric current recommendations include treadmill walking 3–5 days/wk upwardly to the signal of mild to moderate pain (35). In one case pain is experienced, subjects are encouraged to remainder and repeat the bout of exercise when symptoms resolve. In animals with experimentally induced limb ischemia, practise training leads to angiogenesis and collateralization (35); whether this occurs in humans is unclear. Resistance grooming, arm ergometry, and modified cross country skiing have as well shown positive benefits (35). It is of import to emphasize that supervised programs are more effective than home-based programs (70). However, unlike cardiac rehabilitation programs, health insurance typically does not cover practise for PAD patients (35). Whether practise training is equal to or more constructive than surgical intervention has been debated (18, 56, 61). Nonetheless, there is sufficient evidence that whole trunk dynamic practise provides primary and secondary benefits in PAD. On a physiological level, these benefits are due to complex interactions between oxygen delivery and oxygen extraction in skeletal musculus.
Mechanical therapy.
Patients with moderate to advanced PAD (Fontaine II-IV) are often unwilling or unable to exercise at the required intensity needed to achieve cardiovascular and functional benefit. For this reason, several mechanical devices have been developed that act on the arterial and/or venous systems. The nigh commonly studied therapy is intermittent pneumatic pes and dogie compression (IPCC). Using the physiological principles set for by Le Dentu in 1867 (51) IPCC facilitates the venous emptying of the foot veins into the more proximal leg veins. Aggrandizement pressures ranging from 85 to 180 mmHg are delivered to the pes and/or calf for two–4 south, and this compression is followed by 16–20 s of rest (deflation). This paradigm is recommended for 2–six h/day and allows for sustained menses while the veins refill (23–25, 46). Patients with both claudication and disquisitional limb ischemia take experienced improvements in walking distance, improved quality of life, improved ABI, reduced leg pain, and reduced incidence of amputation (22, 45, 59). This is important for critical limb ischemia patients because they would not unremarkably be encouraged to participate in a dynamic exercise program. The mechanisms by which this occurs accept been widely speculated (23, 24, 46, 49, 69) only until recently take not been directly tested: i) increased arteriovenous force per unit area gradient; 2) production of vasodilator substances due to increased shear stress; and iii) inhibition of the venoarteriolar reflex (which would unremarkably human action to impair claret flow when the limb is dependent). Recent studies in rodents investigated the effect of intermittent pneumatic leg compression on skeletal muscle performance, practice tolerance, blood period, oxidative capacity, and capillary contacts (73). The investigators found that two wk of daily treatment enhanced do performance and increased blood menstruation to the plantaris muscle compared with sham-operated animals. Another study from the aforementioned group found that intermittent compression transiently altered the expression of some (e.chiliad., CYR61 and CTGF), but not all (eastward.g., VEGF), genes in human subjects (77). On a physiological level, these cited studies importantly assistance analyze the mechanisms past which intermittent pinch provides clinical benefits.
Two other mechanical therapies include enhanced external counterpulsation (EECP) and remote ischemic preconditioning (RIPC). EECP is an effective therapy for the treatment of refractory angina and utilizes principles of hemodynamics in relation to each cardiac cycle (58). The patient is situated in the semi-supine posture with cuffs on the lower legs, thighs, and buttocks. During early diastole, the cuffs sequentially and rapidly inflate to suprasystolic force per unit area (distal to proximal); during end diastole the cuffs simultaneously deflate. This occurs for 60 min, five times/wk for 7 wk. Past unloading the vasculature during systole and augmenting diastole, cardiac output is increased. Additional benefits are long lasting and include reduced proinflammatory markers, improved endothelial part, and reduced arterial stiffness (58). A diagnosis of PAD has been considered a relative contraindication for EECP just recent studies have indicated its safety (7). Many of the cardiac patients who benefit from EECP likely have systemic atherosclerotic disease (i.e., across just refractory angina). The concept that EECP might ameliorate both limb and cardiac function in PAD needs to be prospectively tested. We should emphasize that the use of EECP in PAD patients must be performed in a medically supervised facility, and discussion should progress to standardize prescreening tests (e.g., imaging, blood panels) to minimize risk to the patient.
Like to EECP, RIPC has gained attention in contempo years, albeit in patients with coronary disease, not necessarily PAD (47). The fact that astute limb ischemia may protect against futurity limb or coronary ischemia is an bonny notion for patients who are unable to undergo practice grooming or who do not respond to medical therapy. By making an arm or leg ischemic for five min, a cascade of hemodynamic and biochemical events occur that announced to offering both short-term and long-term systemic cardioprotection (four). Many of these studies have been performed in nonhuman models, but recent evidence suggests that iii–5 cycles of 5 min upper arm ischemia followed by reperfusion reduces infarction size and reduces troponin levels in cardiac patients (47). Whether a like upshot is seen in PAD patients remains to be directly tested. Compared with IPCC, EECP and RIPC modalities have not been comprehensively investigated, but we believe there is a physiological rationale for why they could/should be effective in PAD. RIPC is the shortest duration stimulus and also the to the lowest degree expensive, but the magnitude and elapsing of clinical benefits is currently unknown.
SUMMARY AND FUTURE DIRECTIONS
PAD is a common and progressive atherosclerotic affliction that is closely linked with cardiac and cerebrovascular mortality. Its authentication symptom, intermittent claudication, is provoked past moderate to vigorous leg exercise, just less than 25% of patients with PAD experience claudication, which makes the disease challenging to diagnose and treat (43, 75). Despite recent efforts, PAD is underdiagnosed in the chief care setting (44). Because PAD is often observed with comorbid weather such as hypertension, dyslipidemia, diabetes, cigarette smoking, and/or physical inactivity, the pathophysiology of PAD is certainly complex (Fig. one). At the nowadays time, there are few studies in PAD patients that isolate crusade-and-effect mechanisms of skeletal musculus metabolic dysfunction, endothelial function, or autonomic circulatory control as the disease progresses. Some other gap in knowledge is how and why mechanical therapies are constructive. Lastly, understanding how the coronary claret vessels and myocardium are contradistinct in response to chronic limb ischemia is a necessary surface area to pursue. Information technology is clear that the subject area of physiology volition remain a driving force for the diagnosis and management of PAD as this field moves frontward.
GRANTS
This work was supported by National Institutes of Health Grants P01 HL096570; (to L.I.S.), UL1 TR000127; (to L.I.Southward.), and R01 HL098379 (to U.A.50.).
DISCLOSURES
No conflicts of involvement, fiscal or otherwise, are declared by the author(south).
Author CONTRIBUTIONS
Author contributions: M.D.Grand., A.B.R., U.A.L., and L.I.South. conception and design of inquiry; M.D.M., A.B.R., U.A.L., and 50.I.S. analyzed data; Chiliad.D.Thousand., A.B.R., U.A.Fifty., and L.I.S. interpreted results of experiments; M.D.Thousand. prepared figures; M.D.Thou. drafted manuscript; M.D.M., A.B.R., U.A.50., and L.I.S. edited and revised manuscript; G.D.Yard., A.B.R., U.A.L., and 50.I.Southward. canonical final version of manuscript.
ACKNOWLEDGMENTS
The authors appreciate the help of Anne Muller in preparing the graphics for this report. Nosotros likewise acknowledge the authoritative guidance of Kris Grayness and Jen Stoner.
REFERENCES
one. Aboyans Five, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, Fowkes FG, Hiatt WR, Jonsson B, Lacroix P, Marin B, McDermott MM, Norgren Fifty, Pande RL, Preux PM, Stoffers HE, Treat-Jacobson D. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation 126: 2890–2909, 2012 [PubMed] [Google Scholar]
2. Baccelli G, Reggiani P, Mattioli A, Corbellini Eastward, Garducci Southward, Catalano M. The practice pressor reflex and changes in radial arterial pressure and heart rate during walking in patients with arteriosclerosis obliterans. Angiology fifty: 361–374, 1999 [PubMed] [Google Scholar]
3. Bakke EF, Hisdal J, Jorgensen JJ, Kroese A, Stranden E. Blood force per unit area in patients with intermittent claudication increases continuously during walking. Eur J Vasc Endovasc Surg 33: twenty–25, 2007 [PubMed] [Google Scholar]
iv. Botker HE, Kharbanda R, Schmidt MR, Bottcher 1000, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Hansen TM, Trautner S, Lassen JF, Christiansen EH, Krusell LR, Kristensen SD, Thuesen Fifty, Nielsen SS, Rehling M, Sorensen HT, Redington AN, Nielsen TT. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and consequence on myocardial relieve in patients with acute myocardial infarction: a randomised trial. Lancet 375: 727–734, 2010 [PubMed] [Google Scholar]
5. Contumely EP, Hiatt WR. Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease. Vasc Med 5: 55–59, 2000 [PubMed] [Google Scholar]
half-dozen. Brass EP, Hiatt WR, Gardner AW, Hoppel CL. Decreased NADH dehydrogenase and ubiquinol-cytochrome c oxidoreductase in peripheral arterial disease. Am J Physiol Eye Circ Physiol 280: H603–H609, 2001 [PubMed] [Google Scholar]
7. Braverman DL, Braitman L, Figeuredo VM. The prophylactic and efficacy of enhanced external counterpulsation as a treatment for angina in patients with aortic stenosis. Clin Cardiol 36: 82–87, 2013 [PMC free article] [PubMed] [Google Scholar]
8. Brendle DC, Joseph LJ, Corretti MC, Gardner AW, Katzel LI. Furnishings of exercise rehabilitation on endothelial reactivity in older patients with peripheral arterial disease. Am J Cardiol 87: 324–329, 2001 [PubMed] [Google Scholar]
9. Brevetti G, Silvestro A, Di Giacomo S, Bucur R, Di Donato A, Schiano V, Scopacasa F. Endothelial dysfunction in peripheral arterial affliction is related to increment in plasma markers of inflammation and severity of peripheral circulatory impairment but non to classic adventure factors and atherosclerotic burden. J Vasc Surg 38: 374–379, 2003 [PubMed] [Google Scholar]
x. Brevetti Yard, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial affliction: additive value of period-mediated dilation to ankle-brachial pressure level alphabetize. Apportionment 108: 2093–2098, 2003 [PubMed] [Google Scholar]
xi. Bruno RM, Ghiadoni L, Seravalle G, Dell'oro R, Taddei S, Grassi G. Sympathetic regulation of vascular role in health and disease. Front Physiol 3: 284, 2012 [PMC gratuitous commodity] [PubMed] [Google Scholar]
12. Casey DP, Joyner MJ. Compensatory vasodilatation during hypoxic do: mechanisms responsible for matching oxygen supply to demand. J Physiol 590: 6321–6326, 2012 [PMC free article] [PubMed] [Google Scholar]
13. Casey DP, Joyner MJ. Local control of skeletal musculus claret flow during practise: influence of bachelor oxygen. J Appl Physiol 111: 1527–1538, 2011 [PMC free article] [PubMed] [Google Scholar]
xiv. Casey DP, Joyner MJ. Skeletal muscle blood menstruum responses to hypoperfusion at residue and during rhythmic exercise in humans. J Appl Physiol 107: 429–437, 2009 [PMC free article] [PubMed] [Google Scholar]
15. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in salubrious immature adults. Circulation 88: 2149–2155, 1993 [PubMed] [Google Scholar]
16. Clagett GP, Sobel M, Jackson MR, Lip GYH, Tangelder M, Verhaeghe R. Antithrombotic therapy in peripheral arterial occlusive disease. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 609S–626S, 2004 [PubMed] [Google Scholar]
17. Coppola G, Romano G, Corrado E, Grisanti RM, Novo S. Peripheral artery disease: potential role of ACE-inhibitor therapy. Vasc Health Adventure Manag iv: 1179–1187, 2008 [PMC free article] [PubMed] [Google Scholar]
18. Creasy TS, McMillan PJ, Fletcher EW, Collin J, Morris PJ. Is percutaneous transluminal angioplasty better than practise for claudication? Preliminary results from a prospective randomised trial. Eur J Vasc Surg four: 135–140, 1990 [PubMed] [Google Scholar]
19. Criqui MH, Denenberg JO. The generalized nature of atherosclerosis: how peripheral arterial disease may predict adverse events from coronary artery affliction. Vasc Med 3: 241–245, 1998 [PubMed] [Google Scholar]
20. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326: 381–386, 1992 [PubMed] [Google Scholar]
21. Cushman M, Lemaitre RN, Kuller LH, Psaty BM, Macy EM, Sharrett AR, Tracy RP. Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 19: 493–498, 1999 [PubMed] [Google Scholar]
22. de Haro J, Acin F, Florez A, Bleda S, Fernandez JL. A prospective randomized controlled study with intermittent mechanical compression of the calf in patients with claudication. J Vasc Surg 51: 857–862, 2010 [PubMed] [Google Scholar]
23. Delis KT, Nicolaides AN. Effect of intermittent pneumatic compression of foot and dogie on walking altitude, hemodynamics, and quality of life in patients with arterial claudication: a prospective randomized controlled written report with 1-yr follow-up. Ann Surg 241: 431–441, 2005 [PMC free article] [PubMed] [Google Scholar]
24. Delis KT, Nicolaides AN, Wolfe JH, Stansby G. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot pinch: a prospective controlled study with one-yr follow-up. J Vasc Surg 31: 650–661, 2000 [PubMed] [Google Scholar]
25. Delis KT, Slimani One thousand, Hafez HM, Nicolaides AN. Enhancing venous outflow in the lower limb with intermittent pneumatic pinch. A comparative haemodynamic analysis on the effect of pes vs calf vs foot and calf compression. Eur J Vasc Endovasc Surg xix: 250–260, 2000 [PubMed] [Google Scholar]
26. Despas F, Lambert E, Vaccaro A, Labrunee M, Franchitto N, Lebrin M, Galinier Thou, Senard JM, Lambert G, Esler Yard, Pathak A. Peripheral chemoreflex activation contributes to sympathetic baroreflex damage in chronic eye failure. J Hypertens 30: 753–760, 2012 [PubMed] [Google Scholar]
27. Duncker DJ, Bache RJ. Regulation of coronary blood catamenia during exercise. Physiol Rev 88: 1009–1086, 2008 [PubMed] [Google Scholar]
28. Duscha BD, Robbins JL, Jones WS, Kraus WE, Lye RJ, Sanders JM, Allen JD, Regensteiner JG, Hiatt WR, Addendum BH. Angiogenesis in skeletal musculus precede improvements in peak oxygen uptake in peripheral artery disease patients. Arterioscler Thromb Vasc Biol 31: 2742–2748, 2011 [PMC free article] [PubMed] [Google Scholar]
29. Esler Chiliad. The 2009 Carl Ludwig Lecture: Pathophysiology of the man sympathetic nervous arrangement in cardiovascular diseases: the transition from mechanisms to medical management. J Appl Physiol 108: 227–237, 2010 [PubMed] [Google Scholar]
30. Falk Eastward. Pathogenesis of atherosclerosis. J Am Coll Cardiol 47: C7–C12, 2006 [PubMed] [Google Scholar]
31. Gardner AW, Montgomery PS, Flinn WR, Katzel LI. The effect of exercise intensity on the response to exercise rehabilitation in patients with intermittent claudication. J Vasc Surg 42: 702–709, 2005 [PubMed] [Google Scholar]
32. Gokce North, Keaney JF, Jr, Hunter LM, Watkins MT, Menzoian JO, Vita JA. Hazard stratification for postoperative cardiovascular events via noninvasive assessment of endothelial role: a prospective study. Circulation 105: 1567–1572, 2002 [PubMed] [Google Scholar]
33. Golomb BA, Dang TT, Criqui MH. Peripheral arterial affliction: morbidity and bloodshed implications. Circulation 114: 688–699, 2006 [PubMed] [Google Scholar]
34. Grassi G, Seravalle G, Calhoun DA, Bolla GB, Giannattasio C, Marabini M, Del Bo A, Mancia G. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 90: 248–253, 1994 [PubMed] [Google Scholar]
35. Hamburg NM, Balady GJ. Practice rehabilitation in peripheral artery disease: functional touch and mechanisms of benefits. Circulation 123: 87–97, 2011 [PMC free article] [PubMed] [Google Scholar]
36. Hiatt WR. Medical handling of peripheral arterial disease and claudication. North Engl J Med 344: 1608–1621, 2001 [PubMed] [Google Scholar]
37. Hiatt WR, Nawaz D, Brass EP. Carnitine metabolism during exercise in patients with peripheral vascular disease. J Appl Physiol 62: 2383–2387, 1987 [PubMed] [Google Scholar]
38. Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP. Benefit of exercise workout for patients with peripheral arterial illness. Circulation 81: 602–609, 1990 [PubMed] [Google Scholar]
39. Hiatt WR, Regensteiner JG, Wolfel EE, Bear MR, Brass EP. Effect of exercise training on skeletal musculus histology and metabolism in peripheral arterial disease. J Appl Physiol 81: 780–788, 1996 [PubMed] [Google Scholar]
40. Hiatt WR, Wolfel EE, Meier RH, Regensteiner JG. Superiority of treadmill walking exercise versus force training for patients with peripheral arterial illness. Implications for the mechanism of the training response. Circulation 90: 1866–1874, 1994 [PubMed] [Google Scholar]
41. Hiatt WR, Wolfel EE, Regensteiner JG, Brass EP. Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease. J Appl Physiol 73: 346–353, 1992 [PubMed] [Google Scholar]
42. Hijmering ML, Stroes ES, Olijhoek J, Hutten BA, Blankestijn PJ, Rabelink TJ. Sympathetic activation markedly reduces endothelium-dependent, menstruum-mediated vasodilation. J Am Coll Cardiol 39: 683–688, 2002 [PubMed] [Google Scholar]
43. Hirsch AT, Criqui MH, Care for-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR. Peripheral arterial disease detection, awareness, and handling in principal care. JAMA 286: 1317–1324, 2001 [PubMed] [Google Scholar]
44. Hirsch AT, White potato TP, Lovell MB, Twillman G, Treat-Jacobson D, Harwood EM, Mohler ER, 3rd, Creager MA, Hobson RW, 2d, Robertson RM, Howard WJ, Schroeder P, Criqui MH. Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey. Apportionment 116: 2086–2094, 2007 [PubMed] [Google Scholar]
45. Kakkos SK, Geroulakos Yard, Nicolaides AN. Improvement of the walking ability in intermittent claudication due to superficial femoral artery apoplexy with supervised practice and pneumatic foot and dogie compression: a randomised controlled trial. Eur J Vasc Endovasc Surg 30: 164–175, 2005 [PubMed] [Google Scholar]
46. Kavros SJ, Delis KT, Turner NS, Voll AE, Liedl DA, Gloviczki P, Rooke TW. Improving limb salvage in critical ischemia with intermittent pneumatic compression: a controlled study with eighteen-month follow-up. J Vasc Surg 47: 543–549, 2008 [PubMed] [Google Scholar]
47. Kharbanda RK, Nielsen TT, Redington AN. Translation of remote ischaemic preconditioning into clinical practice. Lancet 374: 1557–1565, 2009 [PubMed] [Google Scholar]
48. Kinlay S. Outcomes for clinical studies assessing drug and revascularization therapies for claudication and critical limb ischemia in peripheral artery affliction. Circulation 127: 1241–1250, 2013 [PMC costless article] [PubMed] [Google Scholar]
49. Labropoulos North, Leon LR, Jr, Bhatti A, Melton Southward, Kang SS, Mansour AM, Borge M. Hemodynamic effects of intermittent pneumatic compression in patients with disquisitional limb ischemia. J Vasc Surg 42: 710–716, 2005 [PubMed] [Google Scholar]
fifty. Langlois M, Duprez D, Delanghe J, De Buyzere Thou, Cloudless DL. Serum vitamin C concentration is low in peripheral arterial illness and is associated with inflammation and severity of atherosclerosis. Apportionment 103: 1863–1868, 2001 [PubMed] [Google Scholar]
51. Le Dentu A. Circulation veineuse du Pied et de la Jambre. Thesis Number 276: Paris, 1867 [Google Scholar]
52. Leng GC, Horrobin DF, Fowkes FG, Smith FB, Lowe GD, Donnan PT, Ells K. Plasma essential fat acids, cigarette smoking, and dietary antioxidants in peripheral arterial affliction. A population-based case-control study. Arterioscler Thromb 14: 471–478, 1994 [PubMed] [Google Scholar]
53. Levick SP, Murray DB, Janicki JS, Brower GL. Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive eye. Hypertension 55: 270–276, 2010 [PMC complimentary commodity] [PubMed] [Google Scholar]
54. Li J, Xing J. Muscle afferent receptors engaged in augmented sympathetic responsiveness in peripheral artery disease. Front Physiol iii: 247, 2012 [PMC free article] [PubMed] [Google Scholar]
55. Lorentsen E. Systemic arterial blood pressure during exercise in patients with atherosclerosis obliterans of the lower limbs. Circulation 46: 257–263, 1972 [PubMed] [Google Scholar]
56. Lundgren F, Dahllof AG, Lundholm K, Schersten T, Volkmann R. Intermittent claudication–surgical reconstruction or physical training? A prospective randomized trial of treatment efficiency. Ann Surg 209: 346–355, 1989 [PMC costless commodity] [PubMed] [Google Scholar]
57. McDermott MM, Ades P, Guralnik JM, Dyer A, Ferrucci 50, Liu K, Nelson M, Lloyd-Jones D, Van Horn L, Garside D, Kibbe Grand, Domanchuk Thou, Stein JH, Liao Y, Tao H, Green D, Pearce WH, Schneider JR, McPherson D, Laing ST, McCarthy WJ, Shroff A, Criqui MH. Treadmill practise and resistance preparation in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA 301: 165–174, 2009 [PMC complimentary article] [PubMed] [Google Scholar]
58. Michaels AD, McCullough PA, Soran OZ, Lawson We, Barsness GW, Henry TD, Linnemeier G, Ochoa A, Kelsey SF, Kennard ED. Primer: practical approach to the pick of patients for and awarding of EECP. Nat Clin Pract Cardiovasc Med iii: 623–632, 2006 [PubMed] [Google Scholar]
59. Montori VM, Kavros SJ, Walsh EE, Rooke TW. Intermittent compression pump for nonhealing wounds in patients with limb ischemia. The Mayo Dispensary experience (1998–2000). Int Angiol 21: 360–366, 2002 [PubMed] [Google Scholar]
lx. Muller MD, Drew RC, Blaha CA, Mast JL, Cui J, Reed AB, Sinoway LI. Oxidative stress contributes to the augmented practise pressor reflex in peripheral arterial illness patients. J Physiol 590: 6237–6246, 2012 [PMC free commodity] [PubMed] [Google Scholar]
61. Spud TP, Cutlip DE, Regensteiner JG, Mohler ER, Cohen DJ, Reynolds MR, Massaro JM, Lewis BA, Cerezo J, Oldenburg NC, Thum CC, Goldberg S, Jaff MR, Steffes MW, Comerota AJ, Ehrman J, Care for-Jacobson D, Walsh ME, Collins T, Badenhop DT, Bronas U, Hirsch AT. Supervised practise versus chief stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: do versus endoluminal revascularization (CLEVER) study. Circulation 125: 130–139, 2012 [PMC complimentary commodity] [PubMed] [Google Scholar]
62. Narkiewicz K, van de Borne PJ, Hausberg M, Cooley RL, Winniford Dr., Davison DE, Somers VK. Cigarette smoking increases sympathetic outflow in humans. Circulation 98: 528–534, 1998 [PubMed] [Google Scholar]
63. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark Grand, Polak JF, Powe NR, Siscovick D. Ankle-arm alphabetize as a predictor of cardiovascular disease and bloodshed in the Cardiovascular Wellness Written report. The Cardiovascular Health Study Grouping. Arterioscler Thromb Vasc Biol 19: 538–545, 1999 [PubMed] [Google Scholar]
64. Norgren Fifty, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-society consensus for the management of peripheral arterial disease (TASC Two). J Vasc Surg 45, Suppl S: S5–S67, 2007 [PubMed] [Google Scholar]
65. Paton JF, Sobotka PA, Fudim Grand, Engleman ZJ, Hart EC, McBryde FD, Abdala AP, Marina N, Gourine AV, Lobo M, Patel N, Burchell A, Ratcliffe L, Nightingale A. The carotid body as a therapeutic target for the treatment of sympathetically mediated diseases. Hypertension 61: 5–13, 2013 [PubMed] [Google Scholar]
66. Pellegrino T, Storto G, Filardi PP, Sorrentino AR, Silvestro A, Petretta M, Brevetti Thousand, Chiariello Grand, Salvatore One thousand, Cuocolo A. Human relationship between brachial artery flow-mediated dilation and coronary catamenia reserve in patients with peripheral artery disease. J Nucl Med 46: 1997–2002, 2005 [PubMed] [Google Scholar]
67. Philipp CS, Cisar LA, Kim HC, Wilson Air-conditioning, Saidi P, Kostis JB. Association of hemostatic factors with peripheral vascular disease. Am Centre J 134: 978–984, 1997 [PubMed] [Google Scholar]
68. Prabhakar NR, Kumar GK, Peng YJ. Sympatho-adrenal activation by chronic intermittent hypoxia. J Appl Physiol 113: 1304–1310, 2012 [PMC free article] [PubMed] [Google Scholar]
69. Ramaswami M, D'Ayala M, Hollier LH, Deutsch R, McElhinney AJ. Rapid foot and calf compression increases walking distance in patients with intermittent claudication: results of a randomized report. J Vasc Surg 41: 794–801, 2005 [PubMed] [Google Scholar]
lxx. Regensteiner JG, Meyer TJ, Krupski WC, Cranford LS, Hiatt WR. Hospital vs domicile-based exercise rehabilitation for patients with peripheral arterial occlusive affliction. Angiology 48: 291–300, 1997 [PubMed] [Google Scholar]
71. Regensteiner JG, Steiner JF, Hiatt WR. Exercise training improves functional status in patients with peripheral arterial affliction. J Vasc Surg 23: 104–115, 1996 [PubMed] [Google Scholar]
72. Rooke TW, Hirsch AT, Misra Southward, Sidawy AN, Beckman JA, Findeiss LK, Golzarian J, Gornik HL, Halperin JL, Jaff MR, Moneta GL, Olin JW, Stanley JC, White CJ, White JV, Zierler RE. 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Affliction (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Centre Association Task Force on Practice Guidelines. J Am Coll Cardiol 58: 2020–2045, 2011 [PMC gratuitous article] [PubMed] [Google Scholar]
73. Roseguini BT, Arce-Esquivel AA, Newcomer SC, Yang HT, Terjung R, Laughlin MH. Intermittent pneumatic leg compressions enhance muscle performance and blood flow in a model of peripheral arterial insufficiency. J Appl Physiol 112: 1556–1563, 2012 [PMC costless commodity] [PubMed] [Google Scholar]
74. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler Md. Renal sympathetic-nervus ablation for uncontrolled hypertension. N Engl J Med 361: 932–934, 2009 [PubMed] [Google Scholar]
75. Selvin East, Erlinger TP. Prevalence of and adventure factors for peripheral arterial disease in the U.s.: results from the National Health and Nutrition Examination Survey, 1999–2000. Apportionment 110: 738–743, 2004 [PubMed] [Google Scholar]
77. Sheldon RD, Roseguini BT, Thyfault JP, Crist BD, Laughlin MH, Newcomer SC. Astute impact of intermittent pneumatic leg compression frequency on limb hemodynamics, vascular function, and skeletal musculus factor expression in humans. J Appl Physiol 112: 2099–2109, 2012 [PMC gratuitous commodity] [PubMed] [Google Scholar]
78. Singh RB, Mengi SA, Xu YJ, Arneja AS, Dhalla NS. Pathogenesis of atherosclerosis: a multifactorial procedure. Exp Clin Cardiol 7: 40–53, 2002 [PMC gratuitous article] [PubMed] [Google Scholar]
79. Thijssen DH, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, Parker B, Widlansky ME, Tschakovsky ME, Greenish DJ. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol 300: H2–H12, 2011 [PMC gratuitous article] [PubMed] [Google Scholar]
lxxx. Tisi PV, Shearman CP. Biochemical and inflammatory changes in the exercising claudicant. Vasc Med 3: 189–198, 1998 [PubMed] [Google Scholar]
81. Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117: 289–296, 2007 [PMC free article] [PubMed] [Google Scholar]
82. Tsuchimochi H, McCord JL, Hayes SG, Koba Southward, Kaufman MP. Chronic femoral artery occlusion augments exercise pressor reflex in decerebrated rats. Am J Physiol Heart Circ Physiol 299: H106–H113, 2010 [PMC free commodity] [PubMed] [Google Scholar]
83. Tsuchimochi H, Yamauchi K, McCord JL, Kaufman MP. Blockade of acid sensing ion channels attenuates the augmented exercise pressor reflex in rats with chronic femoral artery occlusion. J Physiol 589: 6173–6189, 2011 [PMC free article] [PubMed] [Google Scholar]
84. Turton EP, Coughlin PA, Kester RC, Scott DJ. Exercise preparation reduces the acute inflammatory response associated with claudication. Eur J Vasc Endovasc Surg 23: 309–316, 2002 [PubMed] [Google Scholar]
85. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in human being. Lancet two: 997–yard, 1989 [PubMed] [Google Scholar]
86. Waki H, Gouraud SS, Maeda G, Raizada MK, Paton JF. Contributions of vascular inflammation in the brainstem for neurogenic hypertension. Respir Physiol Neurobiol 178: 422–428, 2011 [PubMed] [Google Scholar]
87. Xing J, Gao Z, Lu J, Sinoway LI, Li J. Femoral artery apoplexy augments TRPV1-mediated sympathetic responsiveness. Am J Physiol Eye Circ Physiol 295: H1262–H1269, 2008 [PMC free article] [PubMed] [Google Scholar]
88. Zucker IH, Schultz Hard disk drive, Patel KP, Wang Due west, Gao L. Regulation of central angiotensin blazon one receptors and sympathetic outflow in heart failure. Am J Physiol Heart Circ Physiol 297: H1557–H1566, 2009 [PMC free article] [PubMed] [Google Scholar]
Manufactures from Journal of Applied Physiology are provided hither courtesy of American Physiological Order
What Basic Physiological Change Underlies Most Cardiovascular Disease?,
Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841832/
Posted by: leavellanchey86.blogspot.com
0 Response to "What Basic Physiological Change Underlies Most Cardiovascular Disease?"
Post a Comment